ARCHIVES

Richard Pestell To Lead Lombardi Cancer Cente

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

Clinical Trials Approved In August 2002 By NCI

September 27, 2002

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986

Cancer Meetings Listed

November 1, 1996

Scientist’s Interpretation Of Meta-Analysis On ESAs Turns 180 Degrees Over 72 Hours.

June 8, 2007

NCI Advisory Group, Other Cancer Meetings For Feb., March Listed

January 25, 1991